» Articles » PMID: 34791611

Exercise in Obesity-the Role of Technology in Health Services: Can This Approach Work?

Overview
Journal Curr Obes Rep
Specialty Endocrinology
Date 2021 Nov 18
PMID 34791611
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Physical activity (PA) is an important strategy to prevent and treat obesity. Electronic health (eHealth) interventions, such as wearable activity monitors and smartphone apps, may promote adherence to regular PA and successful weight loss. This review highlights the evidence for eHealth interventions in promoting PA and reducing weight.

Recent Findings: Wearables can increase PA and are associated with moderate weight loss in middle/older-aged individuals, with less convincing effects long-term (> 1 year) and in younger people. Data for interventions such as mobile phone applications, SMS, and exergaming are less robust. Investigations of all eHealth interventions are often limited by complex, multi-modality study designs, involving concomitant dietary modification, making the independent contribution of each eHealth intervention on body weight challenging to assess. eHealth interventions may promote PA, thereby contributing to weight loss/weight maintenance; however, further evaluation is required for this approach to be adopted into routine clinical practice.

Citing Articles

Standardized assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee: Developed in collaboration with the European Heart Rhythm Association (EHRA), the....

Caiani E, Kemps H, Hoogendoorn P, Asteggiano R, Bohm A, Borregaard B Eur Heart J Digit Health. 2024; 5(5):509-523.

PMID: 39318699 PMC: 11417493. DOI: 10.1093/ehjdh/ztae042.


Gut microbiota changes associated with low-carbohydrate diet intervention for obesity.

Li L, Zhao X, Abdugheni R, Yu F, Zhao Y, Ma B Open Life Sci. 2024; 19(1):20220803.

PMID: 38299011 PMC: 10828666. DOI: 10.1515/biol-2022-0803.


Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial.

Coelho C, Dobbie L, Crane J, Douiri A, Learoyd A, Okolo O Int J Obes (Lond). 2023; 47(11):1132-1142.

PMID: 37696925 PMC: 10599987. DOI: 10.1038/s41366-023-01368-4.


Improving Predictability and Effectiveness in Preventive Digital Health Interventions: Scoping Review.

Pedersen K, Schlichter B Interact J Med Res. 2023; 12:e40205.

PMID: 37471129 PMC: 10401197. DOI: 10.2196/40205.


Obesity in children and adolescents: Overview of the diagnosis and management.

Tung J, Poon G, Du J, Wong K Chronic Dis Transl Med. 2023; 9(2):122-133.

PMID: 37305109 PMC: 10249183. DOI: 10.1002/cdt3.58.